Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07333950
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction -- A Multicenter, Prospective, Open-label, Blind Endpoint, Randomized Controlled Trial
Sponsor: Beijing Tiantan Hospital
Interventions
Best Medical Management Endovascular Recanalization Strategy
Updated 1 time since 2026 Last updated: Dec 30, 2025 Started: Jan 1, 2026 Primary completion: Dec 31, 2027 Completion: Dec 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Acute Basilar Artery Occlusion and Endovascular Therapy and is currently actively recruiting participants. Beijing Tiantan Hospital leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Beijing Tiantan Hospital
Data source: Beijing Tiantan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .